Invention Grant
- Patent Title: Phosphaplatin compounds as therapeutic agents for treatment of bone or blood cancers
-
Application No.: US16475170Application Date: 2018-01-05
-
Publication No.: US10668080B2Publication Date: 2020-06-02
- Inventor: Matthew Price , Tyler Ames
- Applicant: Phosplatin Therapeutics LLC
- Applicant Address: US NY New York
- Assignee: Phosplatin Therapeutics LLC
- Current Assignee: Phosplatin Therapeutics LLC
- Current Assignee Address: US NY New York
- Agency: Fox Rothschild LLP
- International Application: PCT/US2018/012490 WO 20180105
- International Announcement: WO2018/129257 WO 20180712
- Main IPC: A61K31/555
- IPC: A61K31/555 ; A61K9/00
Abstract:
Use of (pyrophosphato)platinum(II) or (pyrophosphato)platinum(IV) complexes (“phosphaplatin compounds”), especially (R,R)-1,2-cyclohexanediamine-(dihydrogen pyrophosphato)platinum(II) (or “PT-112”), as therapeutic agents for treatment of bone and blood cancers, or cancers that metastasize to bones, and methods thereof, are disclosed.
Public/Granted literature
- US20190328748A1 PHOSPHAPLATIN COMPOUNDS AS THERAPEUTIC AGENTS FOR TREATMENT OF BONE OR BLOOD CANCERS Public/Granted day:2019-10-31
Information query
